Measles immunity and response to revaccination of a young adult population in Israel

Journal of Medical Virology

Volumn 50, Issue 3, 1996, Pages 249-253

  Mendelson, E ^a   Duvdevani, P ^a   Varsano, N ^a   Lerman, Y ^b   Slepon, R ^b   Dagan, R ^c   Cohen, D ^b   Danon, Y ^b   Shohat, T ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b MEDICAL CORPS   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

HI; IgM; Immunization; Outbreak

Indexed keywords

IMMUNOGLOBULIN M; MEASLES VACCINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; ISRAEL; MAJOR CLINICAL STUDY; MALE; MEASLES; REVACCINATION; VACCINATION;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; FEMALE; HAPLORHINI; HUMANS; IMMUNOGLOBULIN M; ISRAEL; MALE; MEASLES; MEASLES VIRUS; VACCINATION; VERO CELLS;

EID: 0029845817     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199611)50:3<249::AID-JMV7>3.0.CO;2-9     Document Type: Article

References (44)

1. Aaby P, Knudsen K, Jensen TG, Tharup J, et al. (1990): Measles incidence, vaccine efficacy and mortality in two urban African areas with high vaccination coverage. Journal of Infectious Diseases 162:1043-1048.
2. Ammari LK, Bell LM, Hdinka LR (1993): Secondary measles vaccine failure in healthcare workers exposed to infected patients. Infection Control and Hospital Epidemiology 14(2):81-86.
3. Atkinson WL, Hadler SC, Redd SB, Orenstein WA (1991): Measles surveillence - United States. Surveillence summaries 1991. MMWR Morbidity and Mortality Weekly Report-CDC. 41(No. SS-6):1-11.
4. Bass JW, Halstead SB, Fischer GW, Podgore JK, Pearl WR, Schydlower M, Wiebe RA, Ching FM (1976): Booster vaccination with further live attenuated measles vaccine. JAMA 235:31-34.
5. Berger SA (1990): "Viral Infections" in "The Infectious Diseases of Israel." SA Berger (ed.) pp. 104-142. Gefen Publishing House Jerusalem 1991.
6. Black FL (1989): Measles active and passive immunity in a worldwide perspective. In Melnick JL (ed): "Progress in Medical Virology." Basel: Karger, vol 36, pp 1-33.
7. Black FL, Berman LL, Libel M, et al. (1984): Inadequate immunity to measles in children vaccinated at an early age: effect of revaccination. Bulletin WHO 62:315-319.
8. Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR, Orenstein WA (1990): Measles antibody: reevaluation of protective titers. Journal of Infectious Diseases 162:1036-1042.
9. Dagan R, Slater PE, Duvdevani P, Golubev N, Mendelson E (1995): Decay of maternally derived measles antibodies in a highly vaccinated population in Southern Israel. Pediatric Infectious Diseases Journal 14:965-969.
10. Duvdevani P, Varsano N, Mendelson E (1989-1993): Serological surveys for measles immunity in Israel. Annual Reports of the Central Virology Laboratory, Ministry of Health, Israel. 1989 p. 8; 1990 pp. 19-20; 1991 pp. 20-21; 1992 pp. 26-27; 1993 pp. 16-18.
11. Duvdevani P, Varsano N, Mendelson E (1989-1993): Serological surveys for measles immunity in Israel. Annual Reports of the Central Virology Laboratory, Ministry of Health, Israel. 1989 p. 8; 1990 pp. 19-20; 1991 pp. 20-21; 1992 pp. 26-27; 1993 pp. 16-18.
12. Duvdevani P, Varsano N, Mendelson E (1989-1993): Serological surveys for measles immunity in Israel. Annual Reports of the Central Virology Laboratory, Ministry of Health, Israel. 1989 p. 8; 1990 pp. 19-20; 1991 pp. 20-21; 1992 pp. 26-27; 1993 pp. 16-18.
13. Duvdevani P, Varsano N, Mendelson E (1989-1993): Serological surveys for measles immunity in Israel. Annual Reports of the Central Virology Laboratory, Ministry of Health, Israel. 1989 p. 8; 1990 pp. 19-20; 1991 pp. 20-21; 1992 pp. 26-27; 1993 pp. 16-18.
14. Duvdevani P, Varsano N, Mendelson E (1989-1993): Serological surveys for measles immunity in Israel. Annual Reports of the Central Virology Laboratory, Ministry of Health, Israel. 1989 p. 8; 1990 pp. 19-20; 1991 pp. 20-21; 1992 pp. 26-27; 1993 pp. 16-18.
15. Edmonson MB, Addiss DG, McPherson JT, Berg JL, Circo SR, Davis JP (1990): Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA 263:2467-2471.
16. Epidemiological records 1993-1994. Department of Epidemiology, Ministry of Health, State of Israel.
17. Erdman DD, Heath JL, Watson JC, Markowitz LE, Bellini WJ (1993): Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. Journal of Medical Virology 41:44-48.
18. Fuccillo DA, Sever JL (1989): Measles virus. In Schmidt NJ, Emmons RW (eds): "Diagnostic Procedures for Viral Rickettsial and Chlamydial Infections, 6th edition, pp 713-730.
19. Fulginiti VA, Kempe CH (1965): A comparison of measles neutralizing and hemagglutination-inhibition antibody titers in individual sera. American Journal of Epidemiology 1965; 82:135.
20. Gustafson TL, Lievens AW, Brunell PA, et al. (1987): Measles outbreak in a fully immunized secondary school population. New England Journal of Medicine 1987; 316:771-774.
21. Katz SL, Gellin BG (1994): Measles vaccine: Do we need new vaccines or new programs? Science 265:1391-1392.
22. Kawamoto A, Honda T, Ishida K, Ozeki T, Hayashibara H, Shiraki K, Hino S (1995): Two independent outbreaks of measles in partially vaccinated junior high-schools in Tottori, Japan. Archives of Virology 140:349-354.
23. Lerman Y, Riskin-Mashiach S, Cohen D, Slepon R, Shohat T, Harari H, Wiener M, Danon Y (1993): Immunity to measles in young adults in Israel. Infection 21:154-157.
24. Linneman CC, Hegg ME, Rotte TS, Phair JP, Schiff GM (1973): Measles IgM response during reinfection of previously vaccinated children. Journal of Pediatrics 82:798-801.
25. Linnemann CC, Dine MS, Roselle GA, Askey PA (1982): Measles immunity after revaccination: results in children vaccinated before 10 months of age. Pediatrics 69:332-335.
26. Markowitz LE, Preblud SR, Fine PEM, Orenstein WA (1990): Duration of live measles vaccine-induced immunity. Pediatric Infectious Disease Journal 9:101-110.
27. Markowitz LE, Albrecht P, Orenstein WA, Lett SM, Puliese TJ, Farell D (1992): Persistence of measles antibody after revaccination. Journal of Infectious Diseases 1992; 166:205-208.
28. MMWR (1989): Measles prevention: recommendations of Immunization Practices Advisory Committee (ACIP). 38(S-9).
29. MMWR (1992): Measles - United States. 42(19):378-381.
30. MMWR (1993): Absence of reported measles - United States, November. 42(48):925-926.
31. MMWR (1994a): Measles - United States, first 26 weeks: Morbidity and Mortality Weakly Report. 43(37, Sept 23):673-676.
32. MMWR (1994b): General recommendations on immunization - recommendation of the Advisory Committee (ACIP). 43(RR-1).
33. Murphy MD, Brunell PA, Lievenns AW, Shehab AM (1984): Effect of early immunization of antibody response to reimmunization with measles vaccine as demonstrated by ELISA. Pediatrices 74:90-93.
34. Olsha M, Mendelson E, Shohat T, Cohen D, Duvdevani P, Lerman Y, Danon Y (1994): Measles immunity in Israeli young adults: effects of second immunization at 18 years of age. Israel Journal of Medical Science 30:596-599.
35. Orenstein WA, Irvin J, Jennings MR, et al. (1980): Measles in a rural Ohio county. American Journal of Epidemiology 111:777-789.
36. Orenstein WA, Albrecht P, Herrmann KL, Bernier R, Bart KJ, Rovira EZ (1987): The plaque neturalization test as a measure of prior exposure to measles virus. Journal of Infectious Diseases 155:146-149.
37. Orenstein WA, Markowitz LE, Atkinson WA, Himan AR (1994): Worldwide measles prevention. Israel Journal of Medical Science 30:469-480.
38. Pabst HF, Spady DW, Marusyk RG, Carson MM, Chui LW, Juffres MR, Grimstrud KM (1992): Reduced measles immunity in infants in a well vaccinated population. Pediatric Infectious Disease Journal 11:525-529.
39. Shasby DM, Shope TC, Downs H, et al. (1977): Epidemic measles in a highly vaccinated population. New England Journal of Medicine 296:585-589.
40. Swartz TA (1984): Prevention of measles in Israel: implications of a long term partial immunization program. Public Health Reports 99:272-277.
41. Tulchinsky TH, Abed Y, Ginsberg G, Shaheen S, Friedmann JB, Schoenbaum ML, Slater PL (1990): Measles in Israel, the West-Bank and Gaza: continuing incidence and the case for a new eradication strategy. Reviews of Infectious Diseases 12:951-958.
42. Tulchinsky TH (1991): Prevention of measles in Israel: short and long term intervention strategies. Israel Journal of Medical Science 27:22-29.
43. Tulchinsky TH, Ginsberg GM, Abed Y, Angles MT, Akukwe C, Bonn J (1993): Measles control in developing and developed countries: the case for a two dose policy. Bulletin of the WHO 71(1):93-103.
44. Willy ME, Koziol DE, Fleisher T, Koo S, McFarland H, Schmitt J, Wesley R, Hurwitz ES, Henderson DK (1994): Measles immunity in a population of healthcare workers. Infection Control and Hospital Epidemiology 15(1):12-17.